Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009

MLA

Cutsem, E.Van, et al. “Molecular Markers and Biological Targeted Therapies in Metastatic Colorectal Cancer: Expert Opinion and Recommendations Derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009.” Annals of Oncology, vol. 21, June 2010, pp. vi1-vi10. EBSCOhost, https://doi.org/10.1093/annonc/mdq273.

APA

Cutsem, E. V., Dicato, M., Arber, N., Berlin, J., Cervantes, A., Ciardiello, F., Gramont, A. D., Diaz-Rubio, E., Ducreux, M., Geva, R., Glimelius, B., Glynne-Jones, R., Grothey, A., Gruenberger, T., Haller, D., Haustermans, K., Labianca, R., Lenz, H. J., Minsky, B., … Tabernero, J. (2010). Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009. Annals of Oncology, 21, vi1-vi10. https://doi.org/10.1093/annonc/mdq273

Chicago

Cutsem, E. Van, M. Dicato, N. Arber, J. Berlin, A. Cervantes, F. Ciardiello, A. De Gramont, et al. 2010. “Molecular Markers and Biological Targeted Therapies in Metastatic Colorectal Cancer: Expert Opinion and Recommendations Derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009.” Annals of Oncology 21 (June): vi1-vi10. doi:10.1093/annonc/mdq273.